Consensus guidelines for the management of upper respiratory tract infections;Consenso sobre diagnóstico y tratamiento de infecciones de vías respiratorias altas

Medicina (Argentina)

Volumn 72, Issue 6, 2012, Pages 484-494

  Lopardo Dr , Gustavo ^a   Calmaggi, Aníbal ^a   Clara, Liliana ^a   Hara, Gabriel Levy ^a   Mykietiuk, Analía ^a   Pryluka, Daniel ^a   Ruvinsky, Silvina ^a   Vujacich, Claudia ^a   Yahni, Diego ^a   Bogdanowicz, Elizabeth ^a   Klein, Manuel ^a   Furst, María J López ^a   Pensotti, Claudia ^a   Rial, Maria J ^b   Scapellato, Pablo ^a  

^a Sociedad Argentina de Infectología ^*  (Argentina)

^b Micología y Parasitología Clínica SADEBAC   (Argentina)

Author keywords

Acute otitis media; Pharyngitis; Rhinosinusitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; PENICILLIN V;

ACUTE OTITIS MEDIA; ANTIGEN DETECTION; ARGENTINA; ARTICLE; DRUG PREFERENCE; HAEMOPHILUS INFLUENZAE; HUMAN; MEDICAL HISTORY; MORAXELLA CATARRHALIS; OTOSCOPY; PHARYNGITIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRESCRIPTION; RHINOSINUSITIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; UPPER RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ARGENTINA; EVIDENCE-BASED MEDICINE; HUMANS; OTITIS MEDIA; PHARYNGITIS; RHINITIS; SINUSITIS;

EID: 84872123182     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281: 1512-1519.
2. Gross PA, Barrett TL, Dellinger P, et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis 1994; 18: 4.
3. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. Natl Health Stat Report 2008; 8: 1-29.
4. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002; 35: 113-125.
5. Villar H, Jugo M, Santana G, Baserni M, Reil J. Aumento en la prevalencia de Streptococcus beta hemolíticos en hisopados faríngeos en Buenos Aires. Medicina (B Aires) 2005; 65: 311-314.
6. Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med 2001; 134: 506-508.
7. Alcaide ML, Bisno AL. Pharyngitis and epiglottitis. Infect Dis Clin North Am 2007; 21: 449-469.
8. Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001; 134: 509-517.
9. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 2004; 291: 1587-1595.
10. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981; 1: 239-246.
11. Halfon ST, Davies AM, Kaplan O, Lazarov E, Bergner-Rabinowitz S. Primary prevention of rheumatic fever in Jerusalem schoolchildren. 2. Identification of betahemolytic streptococci. Isr J Med Sci 1968; 4: 809-814.
12. Bisno AL. Diagnosing strep throat in the adult patient: do clinical criteria really suffice? Ann Intern Med 2003; 139: 150-151.
13. Gieseker KE, Mackenzie T, Roe MH, Todd JK. Comparison of two rapid Streptococcus pyogenes diagnostic tests with a rigorous culture standard. Pediatr Infect Dis J 2002; 21: 922-927.
14. Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev 2004; 17: 571-580.
15. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985; 253: 1271-1274.
16. Del Mar C, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev 2006; CD000023.
17. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a metaanalysis. BMC Cardiovasc Disord 2005; 5: 11.
18. Regoli M, Chiappini E, Bonsignori F, Galli L, de Martino M. Update on the management of acute pharyngitis in children. Ital J Pediatr 2011; 37: 10.
19. Thomas M, Del Mar C, Glasziou P. How effective are treatments other than antibiotics for acute sore throat? Br J Gen Pract 2000; 50: 817-820.
20. Korb K, Scherer M, Chenot JF. Steroids as adjuvant therapy for acute pharyngitis in ambulatory patients: a systematic review. Ann Fam Med 2010; 8: 58-63.
21. Hayward G, Thompson M, Heneghan C, Perera R, Del Mar C, Glasziou P. Corticosteroids for pain relief in sore throat: systematic review and meta-analysis. BMJ 2009; 339: b2976.
22. Schutz A, Gund HJ, Pschorn U, et al. Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept. Arzneimittelforschung 2002; 52: 194-199.
23. Fischer J, Pschorn U, Vix JM, et al. Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties. Arzneimittelforschung 2002; 52: 256-263.
24. Wessels MR. Clinical practice. Streptococcal pharyngitis. N Engl J Med 2011; 364: 648-655.
25. Feder HM Jr, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics 1999; 103: 47-51.
26. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ 1993; 306: 1170-1172.
27. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119: 1541-1551.
28. Pichichero ME. Treatment and prevention of streptococcal tonsillopharyngitis. In: UpToDate, Dexton DJ, Edwards MS (Ed), UpToDate 2010.
29. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98: 326.
30. Tanz RR, Shulman ST. Streptococcal pharyngitis: the carrier state, definition, and management. Pediatr Ann 1998; 27: 281-285.
31. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006; 55: 1-94.
32. García S, Casco R, Perazzi B, De Mier C, Vay C, Famiglietti A. Resistencia de Neisseria gonorrhoeae a ciprofloxacina según hábitos sexuales. Medicina (B Aires) 2008; 68: 358-362.
33. American Academy of Pediatrics, Subcommittee on Management of Acute Otitis Media. Diagnosis and Management of Acute Otitis Media. Pediatrics 2004; 113: 1451-1465.
34. Lous J, Burton MJ, Felding JU, Ovesen T, Rovers MM, Williamson I. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2005; CD001801.
35. American Academy of Family Physicians; American Academy of Otolaryngology-Head and Neck Surgery; American Academy of Pediatrics Sub-committee on Otitis Media with Effusion. Otitis media with effusion. Pediatrics 2004; 113: 1412-1429.
36. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997; 99: 318-333.
37. Gould JM, Matz PS. Otitis media. Pediatr Rev. 2010; 31: 102-116.
38. López E, Vázquez M, Orlando N, et al. Streptococcus pneumoniae causing acute otitis media (aom): dynamic of serotype distribution in Buenos Aires, Argentina. Poster presentado en: 7th International Symposium on Pneumococci and Pneumococcal Diseases; 2010 March 14-18; Tel Aviv, Israel.
39. Scottish Intercollegiate Guidelines Network. Diagnosis and management of childhood otitis media in primary care. February 2003 En: http://www.sign.ac.uk/pdf/sign66.pdf; consultado 26/11/2010.
40. Coker TR, Chan L, Newberry S, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children. A Systematic Review. JAMA 2010; 304: 2161-2169.
41. Flynn CA, Griffin GH, Schultz JK. Descongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev 2004; CD001727.
42. Van Zuijlen DA, Schilder AG, Van Balen FA, Hoes AW. National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media? Pediatr Infect Dis J 2001; 20: 140-4.
43. Bezáková N, Damoiseaux RA, Hoes AW, Schilder AG, Rovers MM. Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants BMJ 2009; 338: b2525.
44. National Institute for Health and Clinical Excellence. Prescribing of antibiotics for self limiting respiratory tract infections in adults and children in primary care. 2008 (Clinical guideline 69) En: www.nice.org.uk/CG69; consultado 26/11/2010
45. Sanders SL, Glasziou PP, Del Mar C, Rovers M. Antibiotics for acute otitis media in children (Review) Cochrane Database Syst Rev 2009; 1-43.
46. Cates C, Dr Chris Cates' EBM Web Site. En: www.nntonline.net; consultado 11/03/2011
47. Fossati S, Gagetti P, Reijtman V, et al and the Sireva-II Working Group-Argentina. Serotype distribution, antibiotic resistance and coverage of pneumococcal conjugate vaccines (PCV) before their introduction in the National Schedule: Argentina 2000-2011 Póster presentado en: 8th International Symposium on Pneumococci and Pneumococcal Diseases; 2012 March 11-15; Foz de Iguazú, Brasil.
48. Dowell SF, Butler JC, Giebink GS, et al.Acute otitismedia: management and surveillance in an era of pneumococcal resistance- a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999; 18: 1-9.
49. Kozyrskyj A, Klassen TP, Moffatt M, Harvey K. Shortcourse antibiotics for acute otitis media. Cochrane Database Syst Rev 2010; CD001095.
50. Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23: 1209-1223.
51. Gwaltney J. The 10 most common questions about the common cold. Infect Dis Clin Pract 1996; 5: 371-2.
52. Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134: 498-505.
53. Rosenfeld RM, Andes, D, Bhattacharyya, N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137: S1-S31.
54. Bartlett J. IDCP Guidelines: Management of Upper Respiratory Tract Infections - Colds. Infect Dis Clin Pract 1997; 6: 212-216.
55. Benninger MS, Segreti J. Is it bacterial or viral? Criteria for distinguishing bacterial and viral infections. J Fam Pract 2008; 57: S5-S11.
56. Gwaltney JM, Wiesinger B, Patrie J. Acute community-acquired bacterial sinusitis: the value of antimicrobial treatment and the natural history. Clin Infect Dis 2004; 38: 227-233.
57. Hansen JG, Schmidt H, Rosbor J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995; 311: 233-236.
58. Anon JB, Jacobs MR, Poole MD, et al and the Sinus and Allergy Health Partnership (SAHP). Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004; 130: S1-S45.
59. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004; 131: S1-S62.
60. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005; 116: S13-S47.
61. Williams JW Jr, Simel DL, Roberts L, Samsa GP. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med 1992; 117: 705-710.
62. Lindbaek M, Hjortdahl P. The clinical diagnosis of acute purulent sinusitis in general practice-a review. Br J Gen Pract 2002; 52: 491-495.
63. Ramanan R, Khan AN. Sinusitis Imaging. En: http://emedicine.medscape.com/article/384649; consultado 27/2/2011
64. Benninger MS, Appelbaum PC, Denneny JC, Osguthorpe DJ, Stankiewicz JA. Maxillary sinus puncture and culture in the diagnosis of acute rhinosinusitis: the case for pursuing alternative culture methods. Otolaryngol Head Neck Surg 2002; 127: 7-12.
65. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008, CD000243.
66. National Institute for Health and Clinical Excellence. Prescribing of antibiotics for self limiting respiratory tract infections in adults and children in primary care. 2008. (Clinical guideline 69). En: www.nice.org.uk/CG69; consultado 27/2/2011.
67. Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet 2008; 371: 908-914.
68. Piccirillo JF, Mager DE, Frisse ME, Brophy RH, Goggin A. Impact of first-line vs. second-line antibiotics for the treatment of acute uncomplicated sinusitis. JAMA 2001; 286: 1849-1856.
69. Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, Dimopoulos G, Falagas ME. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ 2008; 178: 845-854.
70. Guías para el Diagnóstico y Tratamiento de las Infecciones Respiratorias Altas elaboradas por la Subcomisión de Uso Apropiado de Recursos de la Sociedad Argentina de Infectología (SADI) Guías para el Diagnóstico y Tratamiento de las Infecciones Rinosinusales Agudas. En: http://www.sadi.org.ar/; consultado 27/2/2011.
71. Desrosiers M, Frenkiel S, Hamid QA, et al. Acute bacterial sinusitis in adults: management in the primary care setting. J Otolaryngol 2002; 31: 2S2-2S14.
72. Agence Française de Sécurité Sanitaire des Produits de Santé. Systemic antibiotic treatment in upper and lower respiratory tract infections: official French guidelines. Clin Microbiol Infect 2003; 9: 1162-1178.
73. Benninger MS, Desrosiers M, Klossek JM. Management of Acute Bacterial Rhinosinusitis Current Issues and Future Perspectives. Int J Clin Pract 2006; 60: 190-200.
74. Organización Panamericana de la Salud. Guía para el tratamiento de las enfermedades infecciosas. Washington D.C: OPS, 2004.
75. Worral G. Acute Sinusitis. Can Fam Physician 2008; 54: 82-83.
76. Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol 2009; 67: 161-171.
77. Zalmanovici A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2009; CD005149.